Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julie Taguchi
Observed names:
J Taguchi,
J. Taguchi,
Julie A. Taguchi,
Taguchi, Julie A.
Institution:
Sansum Medical Clinic
Observed institutions:
University of California, Los Angeles,
Oregon Health & Science University,
University of California, Irvine,
Sansum Medical Clinic,
Memorial Healthcare System
OpenAlex ID:
A5039728399
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
2020
·
Sandra M Swain
, David Miles
, et al.
·
The Lancet Oncology
·
960
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
2015
·
Javier Cortés
, Véronique Dieras
, et al.
·
The Lancet Oncology
·
124
PDF
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)
2018
·
Sara Hurvitz
, Rashi Singh
, et al.
·
Therapeutic Advances in Medical Oncology
·
33
PDF
A phase II study of neoadjuvant docetaxel/carboplatin with or without trastuzumab in locally advanced breast cancer: Response and cardiotoxicity
2006
·
H. R. Chang
, D. Slamon
, et al.
·
Journal of Clinical Oncology
·
23
Abstract P5-19-07: Randomized Phase II trial of afatinib alone or with vinorelbine versus investigator's choice of treatment in patients with HER2-positive breast cancer with progressive brain metastases after trastuzumab and/or lapatinib-based therapy: LUX-Breast 3
2015
·
Javier Cortés
, Veronique Dieras
, et al.
·
Cancer Research
·
5
“Everyone Deserves to be Remembered Like This”: Videotaped Autobiography and End-of-Life Discussions Among Those With Serious or Terminal Illness
2017
·
Alexis Coulourides Kogan
, Wesley Kobashigawa
, et al.
·
Journal of Pain and Symptom Management
·
2
To the Editor
2009
·
Julie Taguchi
·
Menopause The Journal of The North American Menopause Society
·
2
Assessing Patient Readiness to Engage in End-of-life Discussions: Development and Pilot Testing of the End-of-Life Readiness Assessment (ERA) Survey (GP719)
2020
·
Alexis Coulourides Kogan
, Julie Taguchi
·
Journal of Pain and Symptom Management
·
1
Development and Pilot Testing of the End-of-life Readiness Assessment (era) Survey
2019
·
Alexis M Coulourides Kogan
, Julie Taguchi
·
Innovation in Aging
·
1
A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study
2018
·
Julie Taguchi
, Christopher Duma
, et al.
·
Journal of Cancer Therapy
PDF
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
2018
·
M. Nezami
, Steve Hager
, et al.
·
Journal of Cancer Therapy
PDF
Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)
2017
·
SA Hurvitz
, DA Martinez
, et al.
·
Cancer Research
Show more works
View as search
Works count:
14
Citation count:
1,151
H-index:
5
I10-index:
4
Year
Topic
Type
